# ImprimisRx CA, Inc., dba ImprimisRx – FDA Inspection, Mar 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/imprimisrx-ca-inc-dba-imprimisrx/9b577143-3469-4f01-8b62-07a123ec609a
Source feed: FDA_Inspections

> FDA inspection 962695 of ImprimisRx CA, Inc., dba ImprimisRx, March 14, 2016. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR part 211. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 962695
- Company Name: ImprimisRx CA, Inc., dba ImprimisRx
- Inspection Date: 2016-03-14
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1010017 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/imprimisrx-ca-inc-dba-imprimisrx/0348a645-ed8b-41d9-8562-d9264b8c7e7d)

Company: https://www.keypedia.com/companies/imprimisrx-ca-inc-dba-imprimisrx/4fe86729-76bc-40f3-ba28-530af52598c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
